Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 9059246.
- Also identified by PMC identifier 1722112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy. Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids. All patients recovered excellent visual acuity. Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.
Medical subject headings
- Antirheumatic Agents
- Cyclophosphamide
- Lupus Erythematosus, Systemic
- Optic Atrophy